CR1 and hepatocellular carcinoma: It is well established that CR-1 levels in sera of patients with non-small cell lung cancers [82], in testicular germ cell-tumors [83], in HCC [83], and in clear cell renal carcinomas [84] is correlated with poor disease outcome.